Researchers report favorable safety and efficacy for a combination device after implantation and at 6 months follow-up among ...

The Integra-D trial shows the device, which provides cardiac contractility modulation and defibrillation, also eases symptoms ...

Impulse Dynamics announced it received FDA and CE Mark approval and launched its miniature next-generation cardiac contractility modulation therapy delivery system. According to a company press ...

On top of performing implantable cardioverter-defibrillator (ICD) functions, the integrated device also delivered appropriate ...

SIOUX CITY (KTIV) - Brad Hedlund has been in and out of appointments with cardiologists dealing with heart failure over the last decade. Hedlund explained his symptoms as “I had no energy. I had no ...

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window "Medical ...

Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Bayer AG; Bristol-Myers Squibb; Medtronic; Merck/Schering Plough; Boston Scientific Corporation; Daiichi-Sankyo/Elil Lilly and Company; Edwards ...

BOSTON, Dec. 14, 2022 /PRNewswire/ -- Valo Health, Inc ("Valo") shared the initial results of a collaborative study with the U.S. Food and Drug Administration (FDA), demonstrating the potential of ...

Cleveland Clinic is the first in the world to implant a dual cardiac device that potentially treats heart failure symptoms. The surgery was part of a clinical study to evaluate the effectiveness of a ...

CLEVELAND, OH (Ivanhoe Newswire) - More than 6.5 million Americans are living with heart failure. In the next five years, that number will grow to 8.5 million people. It’s the leading cause of death ...